| Product dosage: 50mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 90 | $0.46 | $41.05 (0%) | 🛒 Add to cart |
| 120 | $0.41 | $54.74 $49.06 (10%) | 🛒 Add to cart |
| 180 | $0.37 | $82.10 $66.08 (20%) | 🛒 Add to cart |
| 270 | $0.34 | $123.16 $91.12 (26%) | 🛒 Add to cart |
| 360 | $0.32
Best per pill | $164.21 $114.15 (30%) | 🛒 Add to cart |
Synonyms | |||
More info:
amitriptyline
Amitriptyline is a tricyclic antidepressant (TCA) that has been a cornerstone in psychiatric and pain management for decades. Initially developed in the 1960s, it remains widely prescribed off-label for chronic pain conditions, migraine prophylaxis, and various neurological disorders, despite the development of newer drug classes. Its multifaceted mechanism involving serotonin and norepinephrine reuptake inhibition, along with anticholinergic and antihistaminic properties, creates a unique therapeutic profile that newer selective agents often can’t match.
Asendin: Effective Management of Treatment-Resistant Depression - Evidence-Based Review
Before we get to the formal monograph, let me give you the real story on Asendin. We’ve been working with this amoxapine formulation for about six years now, and honestly, the initial trial data looked almost too good. I remember our lead pharmacologist, Dr. Chen, kept saying “the receptor affinity profile looks like someone designed this in a lab specifically for treatment-resistant cases” – which of course someone did, but you know what I mean.
bentyl
Bentyl – known generically as dicyclomine hydrochloride – is an antispasmodic medication primarily used to treat symptoms of irritable bowel syndrome (IBS), specifically cramping and abdominal pain. It belongs to the anticholinergic class of drugs and works by relaxing the smooth muscles in the gut. Available by prescription in oral tablet, capsule, and liquid forms, and occasionally administered via injection in hospital settings for acute episodes, it’s a cornerstone in managing functional bowel disorders when lifestyle modifications alone prove insufficient.
Elavil: Multimodal Relief for Depression and Chronic Pain - Evidence-Based Review
Elavil, known generically as amitriptyline, is a tricyclic antidepressant (TCA) that has been a cornerstone in psychiatric and pain management for decades. Initially approved by the FDA in the early 1960s for major depressive disorder, its utility has expanded significantly off-label due to its multifaceted pharmacological profile. It’s not just an antidepressant; it’s a versatile agent for chronic pain, migraine prophylaxis, and certain sleep disorders. The drug’s staying power in an era of newer antidepressants speaks to its unique efficacy in complex cases where selective serotonin reuptake inhibitors (SSRIs) fall short.
endep
Endep, known generically as amitriptyline, represents one of those foundational psychotropic medications that somehow manages to stay relevant decade after decade despite the parade of newer antidepressants. It’s a tricyclic antidepressant (TCA) primarily indicated for major depressive disorder, but its utility extends far beyond that, into neuropathic pain management, migraine prophylaxis, and other off-label uses that keep it in our modern therapeutic arsenal. Its mechanism, deeply rooted in the reuptake inhibition of serotonin and norepinephrine, provides a broad physiological effect that newer, more selective agents sometimes lack.
flexeril
Flexeril, generically known as cyclobenzaprine, is a centrally-acting muscle relaxant structurally related to tricyclic antidepressants. It’s primarily indicated as an adjunct to rest and physical therapy for relief of muscle spasm associated with acute, painful musculoskeletal conditions. Unlike peripherally-acting agents, Flexeril works at the brainstem level rather than directly on skeletal muscle, which explains both its efficacy profile and side effect spectrum. We’ve been using it for decades, yet I still find residents surprised when I explain it’s not actually relaxing the muscle itself—it’s modulating the central nervous system’s response to spasm.
Fluoxetine: Effective Symptom Management for Mood and Anxiety Disorders - Evidence-Based Review
Fluoxetine, a selective serotonin reuptake inhibitor (SSRI), stands as one of the most extensively studied and prescribed antidepressants globally. Initially approved by the FDA in 1987, it has fundamentally reshaped the landscape of psychiatric pharmacotherapy. Its significance extends beyond major depressive disorder, with robust evidence supporting its use across a spectrum of conditions from obsessive-compulsive disorder to premenstrual dysphoric disorder. The molecule’s unique pharmacokinetic profile, including a long half-life and an active metabolite, contributes to both its therapeutic benefits and its distinctive side effect and discontinuation syndrome profile.
isofair
Isofair represents one of those rare clinical tools that actually changed my practice patterns. When the first samples arrived from the German research consortium, I’ll admit I was skeptical—another “breakthrough” supplement that would join the graveyard of overhyped nutraceuticals. But the migraine patient outcomes, particularly in our refractory cluster headache cohort, forced me to reconsider everything I thought I knew about dietary intervention in neurological disorders. ## 1. Introduction: What is Isofair?
Pamelor: Effective Neurotransmitter Modulation for Depression and Chronic Pain - Evidence-Based Review
Pamelor, known generically as nortriptyline, is a tricyclic antidepressant (TCA) that has been a cornerstone in neuropsychiatric treatment for decades. It’s primarily indicated for major depressive disorder but has extensive off-label applications in chronic pain management, migraine prophylaxis, and certain anxiety disorders. What’s fascinating about Pamelor isn’t just its efficacy—it’s the remarkable durability of response we see in clinical practice, something that newer agents sometimes struggle to match. I’ve been prescribing this medication since my residency in the late 1990s, and I still find myself reaching for it when other options fall short, particularly in patients with comorbid neuropathic pain and depression.